Preparation and anesthetic properties of propofol microemulsions in rats.
BACKGROUND
The lipophilicity of propofol has required dispersion in a soybean macroemulsion. The authors hypothesized that the anesthetic properties of propofol are preserved when reformulated as a transparent microemulsion rather than as a turbid macroemulsion and that the dose-response relation can be selectively modified by altering the microemulsion's surfactant type and concentration.


METHODS
Microemulsions of propofol were formulated using purified poloxamer 188 (3%, 5%, 7%), and sodium salt of fatty acids (C(8), C(10), C(12)) in saline and characterized using ternary/binary diagrams, particle sizing, and stability upon dilution. Rats received propofol (10 mg . kg(-1) . min(-1)) as either a microemulsion or a conventional macroemulsion to determine these end points: induction (dose; stunned; loss of lash reflex, righting reflex, withdrawal to toe pinch) and recovery (recovery of lash, righting, withdrawal reflexes). After a 14-day recovery period, rats were crossed over into the opposite experimental limb.


RESULTS
Forty-eight microemulsions (diameter, 11.9-47.7 nm) were formulated. Longer carbon chain length led to a marked increase in the volume of diluent necessary to break these microemulsions. All rats experienced anesthetic induction with successful recovery, although significantly greater doses of propofol were required to induce anesthesia with microemulsions irrespective of surfactant concentration or type than with macroemulsions. The sodium salt of C10 fatty acid microemulsion required the greatest dose and longest time for anesthetic induction.


CONCLUSIONS
Propofol microemulsions cause induction in rats similar to that from macroemulsions. The surfactant concentration and type markedly affect the spontaneous destabilization and anesthetic properties of microemulsions, a phenomenon suggesting a mechanism whereby dose-response relation can be selectively modified.
Morey
Timothy E
TE
Department of Anesthesiology, University of Florida, Gainesville, 32610, USA.
Modell
Jerome H
JH
Shekhawat
Dushyant
D
Grand
Todd
T
Shah
Dinesh O
DO
Gravenstein
Nikolaus
N
McGorray
Susan P
SP
Dennis
Donn M
DM
D018686:Anesthetics, Intravenous / Q000008:administration & dosage* / Q000494:pharmacology; D000818:Animals; D004655:Emulsions; D005260:Female; D008297:Male; D010316:Particle Size; D015742:Propofol / Q000008:administration & dosage* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013501:Surface-Active Agents / Q000008:administration & dosage
D018686:Anesthetics, Intravenous; D004655:Emulsions; D013501:Surface-Active Agents; D015742:Propofol